发明名称 Histone demethylase inhibitors
摘要 The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or amidopyridazine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
申请公布号 US9085534(B2) 申请公布日期 2015.07.21
申请号 US201514592830 申请日期 2015.01.08
申请人 QUANTICEL PHARMACEUTICALS, INC. 发明人 Chen Young K.;Kanouni Toufike;Nie Zhe;Stafford Jeffrey Alan;Veal James Marvin;Wallace Michael Brennan
分类号 C07D213/79;C07D237/24;C07D401/12;C07D405/12;C07D409/12;C07D401/04;C07D213/81 主分类号 C07D213/79
代理机构 Wilson Sonsini Goodrich & Rosati 代理人 Wilson Sonsini Goodrich & Rosati
主权项 1. A method of inhibiting a histone demethylase enzyme comprising contacting the histone demethylase enzyme with a compound of Formula (XI): wherein: Q is —CO2R, —C(O)N(H)CN, —C(O)N(H)OH, or tetrazolyl; R is hydrogen or optionally substituted alkyl; G is —X—Y; X is —C1 alkylene; andY is optionally substituted tetralinyl, optionally substituted tetrahydroquinolinyl, substituted pyridyl, optionally substituted naphthyl, optionally substituted indolyl, optionally substituted benzofuranyl, optionally substituted adamantyl, or optionally substituted indanyl.
地址 San Diego CA US